Status:
COMPLETED
Hypoglycemic Effects of a Dietary Supplement With Inositols, Gymnema Silvestre, Alpha-lactalbumin and Zinc.
Lead Sponsor:
Lo.Li.Pharma s.r.l
Conditions:
Metabolism Disorder
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study is aimed at evaluating the hypoglycemic effects of a dietary supplement that associates the properties of two inositols (myo-inositol and D-chiro-inositol) in the ratio 40:1 to Gymnema sylv...
Eligibility Criteria
Inclusion
- BMI between 30 and 35
- Basal Glycemia between 100 and 125 mg/dl
Exclusion
- Diabetes diagnosis
- Use of food supplements containing inositols, gymnema, alpha-lactalbumin and zinc
- Intolerance to inositols, gymnema, alpha-lactalbumin and zinc
Key Trial Info
Start Date :
June 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2022
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT05348304
Start Date
June 28 2022
End Date
October 12 2022
Last Update
October 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapienza University of Rome
Rome, RM, Italy, 00161